73. Бокерия Л.А. Всероссийского научного общества специалистов по клинической электрофизиологии, аритмологии и кардиостимуляции (ВНОА). Клинические рекомендации по проведению электрофизиологических исследований, катетерной аблации и применению имплантируемых антиаритмических устройств/Л.А. Бокерия, А.Ш. Ревишвили и др. - Москва: Новая редакция - 2013. - 595 с.
74. Epstein, A.E. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) / A.E. Epstein, J.P. DiMarco, K.A. Ellenbogen et al. // J Am Coll Cardiol. - 2008. -Vol.5. - P.1-62.
75. Maury P, Hocini M, Haissaguerre M. Electrical storms in Brugada syndrome: review of pharmacologic and ablative therapeutic options. Indian Pacing Electrophysiol J 2005;5:25-34
76. Antzelevitch C, Patocskai B. Brugada syndrome: Clinical, genetic, molecular, cellular, and ionic aspects. Curr Probl Cardiol. 2016;41(1):7-57
77. Belhassen B. Management of Brugada syndrome 2016: Should all high risk patients receive an ICD? Alternatives to implantable cardiac defibrillator therapy for Brugada syndrome. Circ Arrhythm Electrophysiol. 2016;9(11).pii: e004285
78. Marquez MF, Bonny A, Hernandez-Castillo E, De Sisti A, Gomez-Flores J, Nava S, Hidden-Lucet F, Iturralde P, Cardenas M, Tonet J. Long-term efficacy of low doses of quinidine on malignant arrhythmias in Brugada syndrome with an implantable cardioverter-defibrillator: a case series and literature review. Heart Rhythm 2012; 9:1995-2000
79. Nademanee K, Veerakul G, Chandanamattha P, Chaothawee L, Ariyachaipanich A, Jirasirirojanakorn K, Likittanasombat K, Bhuripanyo K, Ngarmukos T. Prevention of ventricular fibrillation episodes in Brugada syndrome by catheter ablation over the anterior right ventricular outflow tract epicardium. Circulation 2011;123:1270-1279
80. Brugada, J., Pappone, C., Berruezo, A., Vicedomini, G., Manguso, F., Ciconte, G., et al.. Brugada syndrome phenotype elimination by epicardial substrate ablation. Circ. Arrhythm. Electrophysiol. 2015; 8: 1373-1381.
81. Zhang P, Tung R, Zhang Z. et al. Characterization of the epicardial substrate for catheter ablation of Brugada syndrome. Heart Rhythm. 2016;13(11):2151-2158. doi: 10.1016/j.hrthm.2016.07.025
82. Bardy GH, Smith WM, Hood MA, Crozier IG, Melton IC, Jordaens L, et al. An entirely subcutaneous implantable cardioverter-defibrillator. N Engl J Med. 2010;363(1):36-44
83. Brouwer TF, Yilmaz D, Lindeboom R, Buiten MS, Olde Nordkamp LRA, Schalij MJ, et al. Long-term clinical outcomes of subcutaneous versus transvenous implantable defibrillator therapy. J Am Coll Cardiol. 2016;68(19):2047-2055
84. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, Authors/Task Force Members. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;37(27):2129-200. doi: 10.1093/eurheartj/ehw128
85. Rosso R, Glick A, Glikson M, et al. Outcome after implantation of cardioverter defibrillator in patients with Brugada syndrome: a multicenter Israeli study (ISRABRU). Isr Med Assoc J. 2008; 10: 435-439
86. Paul M, Gerss J, Schulze-Bahr E, et al. Role of programmed ventricular stimulation in patients with Brugada syndrome: a meta-analysis of worldwide published data Eur Heart J, 2007; 28: 2126-2133
87. Goldenberg I, Moss AJ, Peterson DR, et al. Risk factors for aborted cardiac arrest and sudden cardiac death in children with the congenital long-QT syndrome. Circulation, 2008; 117: 2184-2191
88. Hazinski MF, Nolan JP, Billi JE, Bottiger BW, Bossaert L, de Caen AR. Part 1: Executive summary: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations. Circulation. 2010;122(16/2):S250-75. doi: 10.1161/CIRCULATIONAHA.110.970897.
89. Kleinman ME, Brennan EE, Goldberger ZD, Swor RA, Terry M, Bobrow BJ. 2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Part 5: Adult Basic Life Support and Cardiopulmonary Resuscitation Quality.Circulation. 2015;132:S414-S435